Role of ryanodine receptor subtypes in initiation and formation of calcium sparks in arterial smooth muscle: comparison with striated muscle by Essin, K. & Gollasch, M.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 135249, 15 pages
doi:10.1155/2009/135249
Review Article
Role of Ryanodine Receptor Subtypes in Initiation and
Formation of Calcium Sparks in Arterial Smooth Muscle:
Comparison with Striated Muscle
Kirill Essin1, 2 and Maik Gollasch1, 2
1Division of Nephrology and Intensive Care Medicine, Department of Medicine, Charite´ Campus Virchow, 13353 Berlin, Germany
2Experimental and Clinical Research Center, 13125 Berlin, Germany
Correspondence should be addressed to Kirill Essin, kirill.essine@charite.de and Maik Gollasch, maik.gollasch@charite.de
Received 22 June 2009; Accepted 22 September 2009
Recommended by Mohamed Boutjdir
Calcium sparks represent local, rapid, and transient calcium release events from a cluster of ryanodine receptors (RyRs) in the
sarcoplasmic reticulum. In arterial smooth muscle cells (SMCs), calcium sparks activate calcium-dependent potassium channels
causing decrease in the global intracellular [Ca2+] and oppose vasoconstriction. This is in contrast to cardiac and skeletal muscle,
where spatial and temporal summation of calcium sparks leads to global increases in intracellular [Ca2+] and myocyte contraction.
We summarize the present data on local RyR calcium signaling in arterial SMCs in comparison to striated muscle and muscle-
specific differences in coupling between L-type calcium channels and RyRs. Accordingly, arterial SMC Cav1.2 L-type channels
regulate intracellular calcium stores content, which in turn modulates calcium efflux though RyRs. Downregulation of RyR2 up
to a certain degree is compensated by increased SR calcium content to normalize calcium sparks. This indirect coupling between
Cav1.2 and RyR in arterial SMCs is opposite to striated muscle, where triggering of calcium sparks is controlled by rapid and direct
cross-talk between Cav1.1/Cav1.2 L-type channels and RyRs. We discuss the role of RyR isoforms in initiation and formation of
calcium sparks in SMCs and their possible molecular binding partners and regulators, which differ compared to striated muscle.
Copyright © 2009 K. Essin and M. Gollasch. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
Ca2+ sparks are local, rapid, and transient calcium release
events from a cluster of ryanodine receptors (RyRs) in the
sarcoplasmic reticulum (SR) (for recent review, see [1]).
These local changes have been visualized by use of fluores-
cent, calcium-sensitive dyes (Fluo-3 (or 4)/AM) in all types
of muscle, including arterial smooth muscle cells (SMCs).
An example of Ca2+ spark recorded in a rat tibial artery
SMC is shown in Figure 1. Ca2+ sparks are characterized
by their spatiotemporal properties: a spatial half-width of
∼2 μm (full-width at half maximum (FWHM)), a rise time
of ∼20 milliseconds, a temporal “half-duration” of ∼50
milliseconds (full duration at half-maximum (FDHM)),
and a peak amplitude of ∼1 F/Fo. The skeletal sparks
are briefer and smaller than those in cardiac and arterial
SMCs.
Ca2+ Sparks in Smooth Muscle. In arterial SMCs, Ca2+
sparks activate the spontaneous transient outward currents
(STOCs) [2, 3]. Simultaneous recording of STOCs and
sparks performed in rat cerebral SMCs revealed that virtually
every spark activates a STOC [4]. STOCs are mediated by
big conductance calcium-activated potassium (BK) channels
located in the plasma membrane. STOCs cause membrane
hyperpolarization, which reduce Ca2+ influx by decreasing
the open-state probability of voltage-dependent Cav1.2 (L-
type) calcium channels, lower the global intracellular [Ca2+],
and oppose vasoconstriction [3] (Figure 2(c)).This is in
contrast to cardiac and skeletal muscle, where spatial and
temporal summation of calcium sparks leads to an increase
in the global intracellular [Ca2+] and myocyte contraction.
The native BK channel is composed of four pore-
forming Slo1 α-subunits and four β-subunits [5]. Four β-
subunit genes have been identified, each coding for proteins
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Figure 1: Calcium spark in a rat tibial artery smooth muscle cell. (a) Series of 8 consecutive laser scanning confocal images (17 milliseconds
apart) illustrating a calcium spark. The calcium spark area is marked by a square and the peak of the calcium spark is indicated by arrows
(b). The myocyte was loaded with the Ca2+ indicator dye fluo-3. Two-dimensional (2D) images were obtained using a Nipkow spinning
disk confocal microscope (Perkin Elmer, UltraView LCI). (b) Three-dimensional plot of fluorescence intensity of the cell shown in (a) at 68
milliseconds. The calcium spark occurred in close proximity to the plasma membrane. (c) Time course of the calcium spark in the marked
area. The amplitude is expressed as F/Fo. F is the fluorescence intensity in the marked area where the spark appeared. Fo is fluorescence
intensity of the same cell area in the absence of calcium spark.
providing different modulatory effects on the pharmacology
and activation gating of the channel. The predominant
subunit in vascular smooth muscle cells is the β1 isoform [6].
In the absence of β1 subunits, heterologeously expressed BK
channels have a dramatically reduced Ca2+ sensitivity and are
open only to a significant extent at very positive membrane
potentials [7]. Cerebral artery smooth muscle cells from
BKβ1−/−mice generate calcium sparks of normal amplitude
and frequency, but STOC frequencies are largely reduced at
physiological membrane potentials [8, 9]. Deletion of the
pore-forming BK channel alpha subunit results in a complete
lack of membrane hyperpolarizing spontaneous K+ outward
currents, suggesting that only BK channel activity underlies
STOCs in arterial smooth muscle [10]. In addition to BK
channels, sparks can activate calcium-dependent chloride
channels to produce transient inward currents (STICs) in
nonarterial smooth muscle [11–13]. In contrast to STICs
(which have been reported in only few types of smooth
muscle), STOCs have been detected in virtually all smooth
muscle.
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Figure 2: Control of calcium sparks by voltage-dependent L-type calcium channels. (a) Ca2+ entry from extracellular space is not required
for calcium release in skeletal muscle. Charge movement within Cav1.1 activates RyR1 channel via a direct physical interaction. Ca2+ efflux
from SR through the opened RyR1 channel activates nearby RyR (RyR3) channels via calcium-induced calcium release (CICR). (b) In
cardiomyocytes Cav1.2 mediates influx of extracellular Ca2+ into cytosol. Ca2+ then binds to and activates RyR2 channels via CICR. (c)
Triggering of calcium sparks is not controlled by rapid, direct cross-talk between Cav1.2 channels and RyRs in smooth muscle cells in
contrast to cardiac and skeletal muscle cells. Instead, Cav1.2 channels contribute to global cytosolic [Ca2+], which in turn influences luminal
SR calcium and thus calcium sparks. SERCA: sarco/endoplasmic reticulum calcium ATPase, BK: big conductance calcium-activated K+
channel.
The spark-activated STOCs are important for the regu-
lation of vascular tone, and defective spark-STOC coupling
is linked to hypertension [8, 9, 14]. The spark-mediated
relaxation of arteries via BK channels is a unique feature
of Ca2+ sparks in arterial smooth muscle cells, making
them different from cardiac and skeletal sparks. Another
important difference is the unique regulation of calcium
sparks by Cav1.x L-type channels.
Ca2+ Sparks in Skeletal Muscle. In skeletal muscle a direct
mechanical interaction of the L-type channel (Cav1.1) and
the RyR (predominantly RyR1) is thought to form the basis
of excitation contraction (E-C) coupling (Figure 2(a)). In
this respect, opening of Cav1.1 channel upon membrane
depolarization acts as a voltage sensor with conformational
changes of the channel leading to a physical interaction with
RyR1, promoting its opening, and triggering the release of
Ca2+ from internal stores (Figure 2(a) and [15, 16]). Thus,
in skeletal myocytes, Ca2+ entry is not required for RyR-
mediated calcium release [17].
Ca2+ Sparks in Cardiac Muscle. In cardiac muscle, such
a Cav1.1-RyR1 mechanical coupling is absent. Instead,
membrane depolarization of cardiac myocytes leads to the
opening of the Cav1.2 L-type calcium channels with Ca2+
influx through the Cav1.2 stimulating the opening of the RyR
(predominantly RyR2) and subsequent Ca2+ release from SR
(Figure 2(b) and [1, 18]). The close association between SR
and plasma membrane is the morphological requisite for
effective calcium induced calcium release (CICR) in cardiac
cells.
Major Differences in Ca2+ Spark Triggering. Unlike CICR
in cardiac muscle, RyR channel opening is not tightly
linked to the gating of L-type Ca2+ channels in action
potential-spiking (phasic), nonarterial smooth muscle [19,
20] and nonspiking (tonic), arterial smooth muscle [21]
(Figure 2(c)). This conclusion is primarily based on the
analysis of latencies between calcium sparks appearing
after Cav1.2 L-type channel opening at different membrane
potentials, with the ability of Ca2+ buffers such as EGTA to
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disrupt CICR and the voltage-sensitivity of the occurrence
of calcium sparks. The effective distance between Cav1.2
and RyR in cardiomyocytes has been estimated to be
<100 nm, while excess concentrations of EGTA (17 mM)
did not disrupt the generation of calcium sparks by Cav1.2
channel openings. This finding is in sharp contrast to
smooth muscle cells. Furthermore, the voltage sensitivity
and latency to occurrence of calcium sparks in arterial
smooth muscle do not correlate with the gating behavior
of the Cav1.2 L-type channel, which is also in contrast
to the characteristics of calcium sparks in cardiac muscle
[22, 23]. Our experiments on conditional, inducible, smooth
muscle-specific Cav1.2 knock-out (SMAKO) mice [24] reveal
that reduced calcium spark amplitudes and frequencies
upon Cav1.2 channel gene inactivation are associated with
reduced SR Ca2+ load [21]. The results demonstrate that
triggering of calcium sparks in arterial smooth muscle is
not controlled by rapid, direct cross-talk between Cav1.2
channels and RyRs, which is in contrast to cardiac and
skeletal muscle cells. Instead, the results clearly show that
Cav1.2 channels contribute to global cytosolic [Ca2+], which
in turn influences luminal SR calcium and thus Ca2+ sparks
in arterial smooth muscle (Figure 2(c)). We also demonstrate
that cytosolic [Ca2+] itself contributes minimally to the acute
triggering of physiologically relevant proportion of calcium
sparks. Instead the most efficacious calcium spark trigger
appears to be the luminal SR Ca2+, which is slowly loaded
via Ca2+ influx through Cav1.2 channels.
The SR Ca2+ content regulates excitability of Ca2+ release
by stimulating RyRs by luminal calcium of Ca2+ available
for release but also seems to regulate the activity of RyR
receptors (for review, see [25, 26]). In the following, we will
discuss the role of RyR receptors subtypes in generation of
calcium sparks in arterial smooth muscle. We will address the
problem of changes in SR Ca2+ load in experiments directed
to resolve RyR-mediated, local Ca2+ signaling and will focus
on sorcin, homer1, and calstabins.
2. RyR Receptors Subtypes and Ca2+ Sparks
RyR channels are tetrameric channel proteins, which are
located in the SR plasma membrane and are capable to
release SR Ca2+ into the cytosol [27]. Three isoforms of RyRs
have been identified (RyR1, RyR2, and RyR3). RyR1 is the
predominant isoform in skeletal muscle, while RyR2 is the
predominant isoform in cardiac muscle. In smooth muscle,
all three isoforms (RyR1, RyR2, and RyR3) are present [28,
29].
There are few drugs to target RyRs with limited isoform
specificity (for recent review, see [30]). All three RyR
isoforms bind the plant alkaloid ryanodine with high affinity.
At low concentrations, ryanodine exhibits agonistic effects,
while at higher concentrations it induces antagonistic effects
on RyRs. Accordingly, calcium spark activity is stimulated by
0.1 ryanodine, but inhibited by 10 μM ryanodine [31]. Caf-
feine can be used to stimulate RyRs. Caffeine at concentra-
tions of >5 mM activates all RyR isoforms with RyR1 being
less sensitive than RyR2 and RyR3 [32, 33]. The massive
release of Ca2+ in response to high mM concentrations of
caffeine reflects the amount of calcium within the SR. Low
concentrations of caffeine (<0.5 mM) increase the Ca2+ spark
frequency [34]. There are several exogenous pharmacological
agents that interact and modulate RyR channels [35]. For
example, these include dantrolene, local anesthetics such as
tetracaine and procaine, and peptide toxins. The usage of
these substances in experimental studies is limited by their
unspecificity. For example, dantrolene, a drug used in the
treatment for malignant hyperthermia, has been reported to
inhibit both RyR1 and RyR3 but not RyR2 [36]. Azumolene
at 1–10 μM, a more water soluble analog of dantrolene,
completely suppresses the frequency of calcium sparks in
skeletal muscle [37]. The interpretation of the results is
difficult since the drug can also block L-type channels [38].
Imperotoxins exhibit also high selectivity for RyRs [39].
Imperotoxin A, a 33-amino acid peptide isolated from the
venom of the African scorpion Pandinus imperator enhances
the activity of both RyR1 and RyR2 channels [40]. It is
equipotent in increasing the calcium sparks frequency in
skeletal and cardiac muscle [41, 42]. Therefore, imperotoxins
cannot distinguish between RyR isoforms involved in the
generation of calcium sparks.
Another tool to study the role of RyR subtypes in Ca2+
sparks generation is gene targeting of RyR isoforms. RyR1
[43], RyR2 [44], and RyR3 [45] knockout mice have been
generated. RyR1 knockout (dispedic) and RyR2 knockout
mice die early during postnatal and embryonic development.
In contrast, RyR3 knockout mice are fertile and display
no gross abnormalities. Death of RyR1−/− mouse is likely
caused by respiratory failure, since knockout neonates fail
to breathe and do not move. Mice lacking RyR2 die at
embryonic day 10 with morphological abnormalities in the
heart tube. Therefore, early studies on RyR calcium signaling
were carried out only on neonatal muscles from RyR2 and
RyR1 knockout mice.
2.1. Skeletal Muscle: RyR1 and RyR3. The neonatal mam-
malian skeletal muscle contains both RyR1 and RyR3 [46,
47]. Studies on intercostal muscle cells of RyR1−/− and
RyR3−/− mouse embryos reveal that both RyR1 and RyR3
isoforms seem to be responsible for calcium sparks [48].
Spatiotemporal sparks properties are not different between
RyR1 and RyR3 knockout cells and disappear only in double
knockout cells lacking both RyR isoforms.
RyR3 is widely expressed in murine skeletal muscles
during the postnatal phase of muscle development but
it is expressed only in some adult mammalian skeletal
muscles [46, 49, 50]. In adult mammalian myofibres, voltage
elicited calcium sparks are not detectable [51]. This can
be explained by the inability to resolve individual sparks
during synchronous and massive voltage-induced calcium
release [52]. Mechanical stress, such as an osmotic shock,
is required to evoke calcium sparks in adult mammalian
skeletal muscles [53]. Osmotic shock-induced calcium sparks
in RyR3 knockout flexor digitorium brevis muscles show
reduced amplitudes and prolonged durations [54]. This
indicates that RyR3, even when expressed at low levels,
is capable to modulate calcium spark properties in adult
murine skeletal muscle. RyR3 when exogenously expressed
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in skeletal muscle lacking other RyR subtypes is sufficient for
calcium sparks production [55]. In contrast to adult skeletal
muscle, amphibian skeletal muscle contains both RyR1 and
RyR3 [56] and is able to generate calcium sparks [51, 57, 58].
A specific interplay between RyR1 and RyR3 for generation
of skeletal muscle calcium sparks has been proposed. In
this model, membrane depolarization activates individual
Cav1.1 channels, which in turn mechanically couple to RyR1
channels (voltage-induced calcium release (VICR)). Calcium
efflux from SR through opened RyR1 channel activates
parajunctional RyR3 channels to induce calcium-induced
calcium release (CICR) (see [52] and Figure 2(a)). A recent
study on adult mice skeletal muscles expressing exogenous
RyR3 supports this view [59]. In this study, overexpression
of RyR3 produced spontaneous and voltage-operated sparks;
whereas overexpression of RyR1 lacked voltage-operated
sparks. However, these results could not been confirmed by
Legrand et al. [60]. In this work, only spontaneous calcium
release activity has been detected in GFP-RyR3 expressing
regions. Further experiments are required to elucidate the
question whether RyR3 is responsible for occurrence of
spontaneous sparks only and/or involved in the generation
of voltage-induced sparks via interplay with RyR1 in skeletal
muscle cells.
2.2. Cardiac Muscle: RyR2. The predominant RyR isofom in
cardiac muscle is RyR2 [56]. Accordingly, this RyR isoform
is essential for cardiac excitation-contraction (E-C) coupling
and cardiac calcium sparks. Cardiac myocytes derived from
stem cells in vitro show calcium sparks activity which was
absent after genetic ablation of RyR2 [61]. Modulation of
RyR2 channel activity is achieved by endogenous regulatory
proteins, including calstabin, sorcin, homer, triadin, junctin,
calsequestrin. In certain heart diseases, these proteins may
fail and be responsible for defective calcium spark signaling
(for review, see [1, 62, 63]). The modulatory effects of
sorcin, homer1 and calstabin on RyR and calcium sparks are
discussed in more detail below.
2.3. Smooth Muscle: RyR1, RyR2, and RyR3. In smooth mus-
cle, all three RyR isoforms are present and may potentially
participate in calcium spark generation. Several studies are
undertaken to address this issue [64–70].
Using an antisense oligonucleotide strategy, it has been
reported that both RyR1 and RyR2 subtypes are required
for generation of calcium sparks in rat portal vein myocytes
[64]. Downregulation of RyR1 and RyR2 isoforms by
antisense oligonucleotides suppresses both voltage-induced
sparks and global 10 mM caffeine induced Ca2+ release, while
antisense oligonucleotides against RyR3 are without effect.
The requirement of RyR1 for depolarization-induced sparks
has also been observed in embryonic detrusor muscle [68].
In this study, calcium sparks are measured in embryonic uri-
nary bladder myocytes isolated from wildtype and RyR1−/−
mice. Depolarization-evoked sparks are present in control
cells but absent in knockout cells. However, spontaneous
spark activity is slightly increased in RyR1−/− cells. While all
three RyR isoforms are detected in myocytes, the expression
of RyR2 and RyR3 is unchanged in RyR1 knockout cells. The
authors conclude that both RyR2 and RyR3 are sufficient
to produce spontaneous calcium sparks. Interestingly, in
embryonic pulmonary vascular smooth muscle cells, the
spontaneous calcium sparks frequency is reduced by genetic
deletion of RyR1, suggesting the functional importance of
RyR1 in spontaneous local Ca2+ release [70].
The contribution of RyR2 to smooth muscle calcium
spark generation is indirectly demonstrated using FKBP12.6
knockout mice [67, 71]. Based on the observation that
FKBP12.6 (or calstabin2) stabilizes RyR2 channel in closed
state, deficiency of FKBP12.6 shows an increase in calcium
spark and STOC frequency, amplitude, and duration in
urinary bladder myocytes, indicating a role of RyR2 in
this action potential-spiking smooth muscle. There is more
direct evidence for the involvement of RyR2 in excitation-
contraction coupling in adult urinary bladder using het-
erozygote RyR+/− mice [69]. The RyR2 mRNA expression
level is approximately twice higher than those of RyR1 and
RyR3 in control +/+ cells indicating predominant expression
of RyR2. In +/− cells, the expression of RyR2 mRNA is
significantly reduced, while RyR1 and RyR3 mRNA expres-
sion are not altered. This reduction of RyR2 expression is
associated with a decrease of STOC frequency and amplitude.
The frequency of depolarization evoked Ca2+ “hot spots,”
that represent local calcium transients consisted of several
merged Ca2+ sparks [72], is also decreased in +/− cells. The
data suggest involvement of RyR2 in spiking smooth muscle
calcium spark production. Genetic ablation of RyR3 does
not altered Ca2+ spark and STOC characteristics in mouse
urinary bladder myocytes [67]. These data indicate a role of
RyR2 in calcium spark signaling in action potential-spiking,
nonarterial smooth muscle. Nevertheless, the role of RyR2
in calcium spark formation in nonspiking (tonic) arterial
smooth muscle cells is unknown.
The first study that has been addressed the role of
RyR isoforms in calcium spark signaling in nonspiking,
arterial smooth muscle has been performed by Lohn et al.
using RyR3−/− mice [65]. In this study, calcium sparks,
STOCs, and myogenic tone of cerebral arteries have been
analyzed. The study shows that cells lacking RyR3 produced
more calcium sparks and STOCs leading to reduced arterial
myogenic tone than wildtype cells. The specific role of
RyR3 in calcium spark signaling in nonspiking smooth
muscle compared to spiking smooth muscle may be caused
by different expression levels and/or splicing variants of
RyR3. Nevertheless, the data show that there is a specific
intermolecular interaction between RyR3 and RyR1/2 in
arterial smooth muscle. A possible explanation is proposed
in this paper based on the report that RyR3 are less sensitive
to Ca2+ dependent inactivation than RyR1 and RyR2 [73].
Accordingly, prolonged Ca2+ release through RyR3 will
inactivate RyR1 and RyR2 channel activity. In line with
this suggestion, deficiency of RyR3 eliminates inactivation
of RyR1 and RyR3 and stimulation calcium sparks/STOCs
activity in arterial smooth muscle. However, other studies do
not report a low sensitivity of RyR3 to Ca2+ inactivation [74].
Further studies are required to clarify the precise molecular
mechanism of RyR-dependent calcium spark signaling and
the role of RyR3 in this process.
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As discussed above, studies on the role of RyR2 in
generation of calcium sparks in arterial smooth muscle are
hampered by the fact that RyR2−/− mice die early during
embryonic development and RyR-dependent elementary
calcium signaling develops relatively late during postnatal
development in arterial smooth muscle [75]. In an attempt
to fill the gap of knowledge, we performed experiments on
rats treated with antisense oligonucleotides (asODNs) to
downregulate RyR2. The approach is based on a recent work
of Reading and Brayden and allows partial downregulation
of channels in situ [76]. In situ suppression of RyR2
expression in cerebral artery myocytes was achieved by
infusion of 1 mmol/L asODNs into the cerebral spinal fluid
of 300 to 400-g Sprague-Dawley rats at a rate of 1 μL per
hour for 7 days via Alzet osmotic pumps that discharged
into the lateral cerebral ventricle. The antisense (AS) and
control scrambled (SC) ODNs sequences for RyR2 were
taken from Coussin et al. [64] and synthesized by BioTeZ,
Berlin, Germany. In some experiments, fluorescein-labeled
AS was used to control the delivery of AS (Figure 3(a), left).
The efficiency of downregulation of RyR2 was controlled
by quantitative TaqMan RT-PCR (Figure 3(a), right). Gene
expression was measured using primers obtained from
Applied Biosystems, Darmstadt, Germany and normalized
by 18S ribosomal RNA expression (for method and primer
sequences, see [77]). After 7 days treatment with ODNs,
rats were killed and freshly isolated cerebral smooth muscle
cells were loaded with calcium-sensitive Fluo-4 AM fluo-
rescent dye (for method, see [75]). We found that 10 mM
caffeine induced calcium release was significantly increased
in AS-treated cells in comparison to SC-treated control
cells (Figure 3(b), left). This indicates that SR Ca2+ load
is upregulated in response to partial suppression of RyR2
by the asODNs. Although calcium spark frequency had a
tendency to increase in AS-treated cells (Figure 3(b), right),
the effect was not significant. Thus, a partial reduction
of RyR2 expression seems to increase SR Ca2+ load to
normalize Ca2+ sparks in rat cerebral artery smooth muscle
cells. Accumulation of Ca2+ inside the SR may have resulted
from an inhibition of Ca2+ efflux through reduced number
of available RyR2 channels. The SR Ca2+ overload, in
turn, may stimulate Ca2+ spark activity through a process
known as store-overload induced Ca2+ release (SOICR)
[78].
3. Intracellular Proteins, Stores Regulation
(SR), and Ca2+ Sparks
The SR Ca2+ load ([Ca2+]SR) does not only determine the
amount of Ca2+ available for release from SR but seems
also to regulate the activity of RyR receptors. In agreement,
luminal Ca2+ has been shown to enhance RyR2 channel
activity (for recent review, see [79]). It has been suggested
that luminal Ca2+ regulates cardiac Ca2+ release channel
activity by passing through the open channel and binding
to the channel’s cytosolic Ca2+ activation sites [80]. An
alternative scenario assumes the existence of Ca2+ sensitive
site(s) at the luminal face of the RyR2 channel [81]. RyR1
channels have been found to be less sensitive to the Ca2+
overload and luminal Ca2+ than RyR2 channels, which has
been proposed as a possible explanation for the lack of spon-
taneous Ca2+ sparks in adult mammalian skeletal muscles
[78]. Ca2+ overload and associated increase in Ca2+ sparks
frequency are detected in rat cardiomyocytes upon treatment
with tetracine (0.75 mM), a membrane-permeant reversible
blocker of RyR2 and RyR1 channels [82]. However, recent
studies on smooth muscle cells explore lower concentrations
of tetracaine (≤50 μM) and reveal that the inhibitory effects
of tetracaine on Ca2+ sparks are rather independent on SR
Ca2+ load [83, 84]. Nevertheless, a good correlation between
SR Ca2+ load and Ca2+ sparks/STOCs activity is observed in
nonspiking, nonarterial smooth muscle [83, 85]. In addition,
genetic ablation of phospholamban, an endogenous inhibitor
of the SR Ca2+-ATPase, leads to a chronic elevation in SR
Ca2+ load and calcium spark frequency in arterial smooth
muscle cells compared to wild type cells [86]. There are
several endogenous proteins known to modulate Ca2+ sparks
activity. The role of calsequestrin, junction, and triadin
is excellently reviewed in [62]. In the following, we will
focus on the natural modulators of RyR channels known
to date, such as sorcin, homer1, and calstabins, and discuss
their functions to regulate calcium sparks and SR Ca2+ load
(Figure 4).
3.1. Sorcin. Sorcin (soluble resistance-related calcium bind-
ing protein) is a 21.6-KDa protein that regulates intracellular
Ca2+ homeostatsis and expressed in a variety of mammalian
tissues including the heart [87], endothelial and smooth
muscle cells of the aorta and cerebral arteries [88]. Expres-
sion of sorcin in rat aorta is ∼2-fold higher than in heart and
small cerebral artery, indicating a prominent role in conduit
arteries [88]. Sorcin reduces the activity of RyR2 in cardiac
SR vesicles incorporated into planar lipid bilayers [87] and
slows inactivation of Cav1.2 in isolated rabbit ventricular
myocytes [89]. Sorcin also induces activation of sodium-
calcium exchanger, sarco/endoplasmic reticulum calcium
ATPase (SERCA)—mediated Ca2+ uptake, and increases in
SR Ca2+ load [90, 91].
Sorcin and Ca2+ Sparks. Sorcin inhibits calcium spark
frequency and alters their characteristics in permeabilized
mouse ventricular myocytes [87] and permeabilized rat
cerebral artery smooth muscle cells [88]. The ability of
sorcin to reduce calcium spark frequency is associated with
its inhibitory effects on RyR. The inhibitory process is
Ca2+ dependent. Sorcin is largely soluble at low [Ca2+]
(<1 μm) and supposedly inactive, but at high [Ca2+] it
undergoes conformational changes that expose hydrophobic
residues and trigger translocation of sorcin from cytosol to
membrane-bound protein targets. In the heart this process
requires a much higher increase in intracellular [Ca2+] (EC50
≈200 μM, [87]) in comparison to SMCs (EC50 = 1.5 μM,
[88]). Rueda et al. assume that this difference reflects the
difference in coupling between the Cav1.2 channels and
RyR2 in cardiac versus smooth muscle cells. According to
their assumption, sorcin translocation in cardiac cells is
initiated only in the dyadic space (the gap between T-tubules
and SR membranes), where the tight interaction between
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Figure 3: In vivo suppression of RyR2 expression by antisense oligonucleotides (AS ODNs) in rat cerebral artery smooth muscle cells leads to
increase of SR Ca2+ content without effects on spontaneous calcium sparks. (a) Left side: Images of rat cerebral arteries isolated 7 days after
continuous i.c.v. injection of the fluorescence-labled AS ODNs (left) and nonlabeled AS ODNs (right) via Alzet osmotic pumps. Right
side: RyR2 mRNA expression normalized to 18S ribosomal mRNA expression in arteries isolated from rats treated by AS ODNs (red) and
scrambled (SC) ODNs (black) (n = 5 rats in each group). (b) Left side: Averaged time course of changes in response to external 10 mM
caffeine in fluorescence intensity in Fluo-4 loaded cerebral artery smooth muscle cells (SMCs) isolated from rats treated with AS ODNs
(red) and SC ODNs (black). The corresponding mean peak amplitudes are presented in the middle plot. Right side: The frequency of
calcium sparks was not different between AS and SC ODNs treated cells. Calcium sparks were recorded in line-scan mode. The number of
cells tested is indicated above each bar. Data are mean ± S.E.M. AU: arbitrary unit.
Cav1.2 and RyR2 generates Ca2+ ←gradients that have
been estimated to reach several hundred micromolars. The
absence of such a tight coupling between Cav1.2 and RyRs in
smooth muscle [19, 21] and therefore the presence of smaller
Ca2+ ←gradients would require a higher calcium sensitivity
of sorcin-RyR2 interaction to be functionally activated in
these cells. The reasons for the remarkable differences in
calcium sensitivity are unclear. One possibility [88] is the
presence of β1-adrenergic inactivation of sorcin via protein
kinase A in cardiac cells [92], which is not noted in smooth
muscle cells.
Sorcin Mutation. A sorcin missense mutation (F112L) has
been associated with hypertrophic cardiomyopathy and
hypertension in two unrelated families [93]. The F112L
mutation results in ∼6-fold decrease in the affinity for
Ca2+ and lack of ability to modulate RyR2 activity [94].
As a result, F112L-sorcin does not decrease the frequency,
amplitude, duration, and spatial spread of calcium sparks
in saponin-permeabilized vascular myocytes [94]. Moreover,
overexpression of F112L-sorcin in transgenic mice increases
calcium spark frequency, duration, and width in cardiomy-
ocytes [91]. The reason for the increased SR Ca2+ content
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Figure 4: Putative role of sorcin, homer1, and calstabins in calcium spark regulation in smooth muscle. Sorcin (soluble resistance-related
Ca2+ binding protein) is a negative regulator of calcium sparks in SMCs. It is activated by increases in cytosolic [Ca2+] (EC50 = 1.5 μM).
Stimulatory effects on Cav1.2 channels and SERCA have also been reported. Calstabin2 (FKBP12.6) associates with RyR2 and stabilizes RyR2
channels in their closed state. FK506, an immunodepressant drug, binds to calstabin2 and can cause dissociation of calstabin2-RyR2 complex
and therefore stimulation of calcium sparks in some smooth muscle tissues. Scaffold protein Homer1 (Ves1) has been shown to stimulate
both RyR2 (at doses <50 nM) and Cav1.2 channels in nonarterial smooth muscle. Based on these findings, Homer1 can be expected to be a
positive regulator of local calcium release calcium in this type of smooth muscle, which, however, has not been demonstrated so far. With
respect to arterial smooth muscle, it is likely that calstabin2 and Homer1 play no role or only a minor role in calcium spark generation.
This speculation is based on our findings that cytosolic [Ca2+] itself contributes minimally to the acute triggering of physiologically relevant
proportion of calcium sparks. Instead the most efficacious calcium spark trigger appears to be the luminal SR Ca2+, which is slowly loaded
via Ca2+ influx through Cav1.2 channels. Arrows indicate positive (red, +) and negative (blue, −) regulation of corresponding targets.
is likely delayed inactivation of Cav1.2 Ca2+ channels, which
has been revealed by overexpression of sorcin. Another
reason could be sorcin mediated activation of SERCA
[90]. However, the vascular phenotype and calcium spark
properties had not been studied.
Therefore, sorcin appears to play an opposite role in
calcium spark regulation. First, it inhibits calcium sparks
by decreasing the activity of RyR2s. Second, it stimulates
calcium sparks by increasing SR Ca2+ content. Under normal
conditions, the inhibitory effect seems to dominate. In
disease, F112L-mutated sorcin lacks the ability to modulate
RyR2 activity, which may unmask the stimulatory effect of
sorcin on calcium sparks frequency [91]. There is no data on
the role or function of sorcin in arterial smooth muscle.
3.2. Homer1. Homer1 (known also as Ves1) belongs to the
Homer scaffolding protein family and modulates not only
the targeting and localization, but also the activity of many
proteins participating in calcium signaling, including RyR1,
RyR2, and Cav1.2 (for recent review, see [95]). In mammals,
the Homer proteins are found in brain, heart, skeletal, and
smooth muscles [96]. There are four Homer1 isoforms:
short Homer1a isoform and long Homer1b/c/d isoforms.
Both long and short isoforms interact with RyR1 and RyR2
through conserved EVH1 domain binding to proline-rich
binding sites on the RyR protein. The effect of Homer1
isoforms on the single channel activity of RyR incorporated
into lipid bilayer is biphasic, being stimulatory at low doses
of Homer1 (<50 nM) and inhibitory at high doses of Homer1
(>200 nM) [97, 98].
Long and Short Homer. Long (1c) and short (1a) Homer1
isoforms dosedependently (0–50 nM) increase the frequency
of calcium sparks in permeabilized skeletal muscle without
significant alteration of their spatiotemporal properties [99].
No changes in calcium sparks are detected upon application
of Homer1c with mutation in the EVH1 binding domain,
what suggest that enhanced calcium spark activity is medi-
ated by an interaction of the EVH1 domain of Homer
with the Homer ligand domain of RyRs. Homer1c isoform
is more effective in increasing the skeletal muscle calcium
spark frequency in comparison with Homer1a, a finding
that correlates with the higher efficiency of Homer1c in
modulation RyR1 [97]. Homer1a, in contrast to long Homer
isoforms, lacks a C-terminal coiled coil (CC) domain that
serves to form a multimeric Homer complex and link the
proteins that bind EVH1 domain. Homer1a stimulates spark
frequency in skeletal muscle, which is most likely induced by
agonistic effects of Homer on RyR1, but not by the capacity
of Homer to link Cav1.1 to RyR1 [99].
Effects on Ca2+ Sparks. The effects of Homer1 on calcium
sparks in cardiac and smooth muscle have not been inves-
tigated so far. However, there is evidence that Homer1
can stimulate Cav1.2 currents in destructor smooth muscle
[100]. Deletion of Homer1 in mice resulted in a ∼40%
reduction of Cav1.2 current. Infusion of either short or long
Homer1 isoforms activates Cav1.2 and restored the current
amplitude in Homer1−/− cells. The intriguing finding is
that despite the significant reduction of Cav1.2 current,
the efficiency of E-C coupling is increased in Homer1−/−
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cells. To explain this finding, the authors propose existence
of a Homer-mediated link between Cav1.2 and RyRs in
this type of smooth muscle. According to this explanation,
long isoforms of Homer1 solidify the interaction between
Cav1.2 and RyRs and reduce the activity of the channels.
Therefore, knockout of Homer1 facilitates the interaction
between the Cav1.2 and RyRs (most likely RyR2) and results
in an increased E-C coupling. In the elegant experiments
performed on HEK cells simultaneously transfected with
Cav1.2, RyR2 and Homer1, the existence of a Homer1-
mediated link between Cav1.2 and RyR2 is confirmed [100].
Experiments on native cardiac and smooth muscle cells are
required to confirm the existence of this pathway in vivo.
Calcium spark measurements in Homer1−/− cells would
be essential to clarify the physiological importance of this
pathway for local calcium signaling.
3.3. Calstabins (FKBPs). Calstabins (FKBPs, or FK506 bind-
ing proteins) represent a family of proteins that exhibit prolyl
isomerase activity and are widely expressed in a variety of
tissues. Two members of the FKBP family, FKBP12 (cal-
stabin1) and FKBP12.6 (calstabin2), can associate and sta-
bilize RyR channels in the closed states (for recent review, see
[101]). The immunosuppressive agents, FK506 (tacrolimus)
and rapamycin (sirolimus), are drugs known to cause
dissociation of FKBP12 from RyR, thus stimulating RyR
channel activity. FK506 disrupts the FKBP12-RyR complex
and forms the FK506-FKBP12 complex, which inhibits the
Ca2+/calmodulin-dependent phosphatase calcineurin [102].
Rapamycin, a structural analog of FK506, can also form
a complex with FKBP12. The rapamycin-FK506 complex
is found to inhibit a protein kinase named mammalian
target of rapamycin (mTOR) [103]. Under physiological
conditions, FKBP12 binds selectively to RyR1, and FKBP12.6
associates predominantly with the RyR2 isoforms [104]. In
this respect, excitation-contraction coupling in general and
calcium sparks in particular can be modulated by calstabins.
Calstabins in Skeletal Muscle. In skeletal muscle, E-C cou-
pling is gained by deficiency FKBP12, as shown in skeletal-
muscle specific FKBP12 knockout mice (SFK12KO mice)
[105]. Calcium sparks properties in SFK12KO cells have
not been studied so far. Nevertheless, a modulatory effect
of FKBP12 on skeletal muscle calcium sparks has been
implicated by experiments in rats with chronic hyper-
adrenergic heart failure, where protein kinase A (PKA)
hyperphosphorylation of RyR is known to decrease calstabin
binding to RyR [106]. Additional support comes from a
recent study using K-201 (known also as JTV519) [107],
a 1,4-benzothiazerpine derivative, a drug that has been
suggested to prevent dissociation of calstabin-RyR complex.
Considering the multiplicity of targets of PKA and K-201,
including their direct action on Cav1.x and SERCA activity,
the reported effects of PKA and K-201 on calcium sparks
cannot be exclusively explained by changes in calstabin-
RyR complex stability. Future work, for example, utilizing
the SFK12KO mice model, is required to determine the
degree by which the decreased gain of skeletal muscle
E-C coupling following disruption of the FKBP12-RyR1
interaction involves alterations in the properties of calcium
sparks.
Calstabins in Cardiac Muscle. In cardiomyocytes, deficiency
of FKBP12.6 leads to an increase in calcium spark amplitude
and duration, which is consistent with an increase in RyR
channel openings [108]. Similarly, inhibition of FKBP by the
FK506 or rapamycin increases calcium spark duration by
6-7 fold in rat ventricular myocytes. However, this finding
is in contrast to data on FKBP12.6 knockout mice, which
show slightly decreased calcium spark amplitudes [109].
Divergent effects of FK506 on Ca2+ transient amplitude can
be related to species differences [110]. An increase in cardiac
spark frequency accompanied by increase of SR Ca2+ content
upon treatment by FK506 has also been reported [111].
Overexpression of FKBP12.6 in cardiomyocytes decreases
the calcium spark frequency (>50%) with little effects on
spatial-temporal characteristics [112–114]. The controversy
raises since rat and rabbit cardiomyocytes overexpressing
FKBP12.6 after adenoviral-mediated gene transfer show an
increased SR calcium load [112, 113], which is not detectable
in mouse cardiomyocytes after conditional cardiac-specific
overexpression of FKBP12.6 [114]. Therefore, despite of
numerous studies of the FKBP12.6 effects on cardiac calcium
sparks, the precise role of FKBP12.6 in local cardiac calcium
signaling, including its contribution to the calcium SR
load, remains to be resolved. To make the picture even
more complicated, recent work on FKBP12.6−/− mice
demonstrates no effect of the calstabin2 loss on the RyR2
activation and spontaneous Ca2+ release [115].
Calstabins in Smooth Muscle. Similar to the situation with
cardiac cells, in mouse urinary bladder smooth muscle
cells, knockout of FKBP12.6 evokes an increase in calcium
spark and STOC frequencies, amplitudes, and durations
[67]. Pharmacological removal of calstabins from RyR by
FK506 induces augmentation of calcium spark and STIC
frequencies, amplitudes, and durations in tracheal smooth
muscle cells [71] and increases STOCs in guinea-pigs urinary
bladder smooth muscle cells [116]. These effects correlate
with the ability of FK506 to increase the open probability
of reconstituted smooth muscle RyR channels [117]. The
effects of FKBP12.6 on caclium sparks in arterial smooth
muscle have not been studied. It is known that in arterial
smooth muscle calcium sparks indirectly cause vasodilation
through activation of BK channels [3]. Based on an increased
spark activity detected in FKBP12.6 knockout smooth mus-
cle cells, a vasodilatory phenotype would be expected in
FKBP12.6−/− mice. Instead, calstabin2 knockout mice are
hypertensive [108], which could be related to endothelial
dysfunction and abolishment of endothelium-dependent
dilations in the absence of calstabin2 [118]. Nevertheless,
calcium sparks and STOCs have not been analyzed in arterial
smooth muscle of these mice, making the interpretation of
the results difficult.
4. Ca2+ Sparks and Functional Disorders
Alterations in Ca2+ spark properties are detected in many
muscle disorders—from skeletal muscle dystrophy and
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cardiac hypertrophy to arterial hypertension. In skeletal
muscle, Ca2+ sparks are silent under resting conditions in
young muscle but can be repeatedly and reversibly activated
upon deformation of membrane structures. The ability to
activate Ca2+ sparks repeatedly is reduced in aged skeletal
muscle [119]. In dystrophic muscle, deformation-induced
Ca2+ sparks are essentially irreversible [53]. Deformations
applied to the skeletal muscle, in the form of osmotic
shock or fatiguing exercise, result in loose control of RyR
function by the L-type channel. Thus, spontaneous Ca2+
sparks are observed. Uncontrolled calcium sparks function
as a dystrophic signal for mammalian skeletal muscle.
Cardiac hypertrophy in spontaneous hypertensive rats
is accompanied by the increase in the amplitude of Ca2+
sparks: big hearts, big sparks [120]. This alteration is
not associated with changes of the density of ryanodine
receptors, calsequestrin, junctin, triadin, SERCA, phospho-
lamban, of the current density of L-type channels and of
the level of SR Ca2+ content. The probable reason for big
sparks in hypertrophic cardiomyocytes is related to elevated
IP3 receptors expression, specifically in the junctional SR
reticulum in close proximity to RyRs [121]. Ca2+ release
via IP3 receptors sensitize RyRs, thereby enhancing Ca2+
release during E-C coupling. Diabetic cardiomyopathy is also
characterized by changes of cardiac sparks amplitude. Ca2+
sparks in cardiomyocytes are smaller in amplitude and less
frequent in obese type 2 diabetic mice in comparison to
control mice, because of decreased SR Ca2+ load and lowered
expression of RyR channels [122]. Reduced amplitude of
Ca2+ transients and depression of SR Ca2+ load is also
observed in streptomycin-induced diabetic rat hearts [123].
Another cardiac disorder that influences function of RyR2
receptors and thus formation of Ca2+ sparks is catecholamin-
ergic polymorphic ventricular tachycardia (CPVT), a form
of exercise-induced sudden cardiac death. Several RyR2
missense gain-of function mutations are found in CPVT
carriers [124, 125]. These mutations decrease the binding
affinity of RyR2 for calstabin-2, a subunit that stabilizes the
closed state of the RyR2 channel. The increased activity of
mutant RyR2 leads to increased frequency of Ca2+ sparks
in mice cardiomyocytes [126]. CPVT is caused also by
mutations in calsequestrin, a Ca2+-storing protein of the SR,
that indirectly inhibit RyR2 function at low luminal Ca2+
[127].
Changes in the efficiency of Ca2+ spark-BK channel
(STOCs) coupling in arterial SMCs are associated with the
arterial hypertension. Arterial hypertension is characterized
by increased arterial vascular tone. Ca2+ sparks in arterial
SMCs activate nearby BK channels providing a hyperpolariz-
ing signal that opposes vasoconstriction [3]. A reduction of
Ca2+ spark-BK channel coupling may cause hypertension. In
angiotensin II-induced hypertension in rats, the expression
of BK channel β1 subunit in cerebral SMCs is downregulated.
This leads to BK channel complexes with a decreased
calcium sensitivity and a decreased ability to be activated
by Ca2+ sparks [14]. BK channel β1 subunit knockout
mice have an increased arterial tone and blood pressure
[8, 9]. Diabetes mellitus has been reported to be associated
with downregulation of BK β1 subunits in retinal arteriolar
smooth muscle of rats [128]. Correspondingly, upregulation
of BK channel β1 subunit in rat mesenteric SMCs induced
by acute hemorrhagic shock results in hypersensitivity of
BK channel to Ca2+ sparks that contributes to hypotension
[129]. Removal of BK channels and loss of Ca2+ spark-BK
channels coupling in corpus cavernosum smooth muscle lead
to penile erectile dysfunction [130].
The properties of Ca2+ sparks and STOCs (amplitude,
frequency, duration, and spatial distribution) are dependent
on the correct function of many colocalized proteins,
including those which determine SR Ca2+ load and modulate
the opening of RyR channels themselves. This makes RyR
signaling prone for many disorders. The appearance of
spontaneous Ca2+ sparks in skeletal muscle could serve as
a marker of dystrophy. “Big” amplitudes of the cardiac
Ca2+ sparks indicate hypertrophy. Loss of Ca2+ spark-BK
channel (STOCs) coupling in arterial smooth muscle cells is
associated with the arterial hypertension. Thus, analysis of
properties of Ca2+ sparks and STOCs could be an important
approach to characterize the functional state of muscle.
5. Perspectives
Despite of several studies performed to reveal the role of RyR
isoforms in initiation and formation of calcium sparks in
smooth muscle cells, the specific involvement of RyR1, RyR2,
and RyR3 in local and global calcium signaling remains
to be elucidated, in particular in arterial smooth muscle
cells. Research progress is limited by the absence of selective
pharmacological drugs and early embryonic and postnatal
lethality of RyR1 and RyR2 knockout mice. Approaches
to partially downregulate RyRs in arterial smooth muscle
(e.g., by antisense oligonucleotides) seem to give results on
local calcium signaling difficult to interpret, since the most
efficacious calcium spark trigger appears to be the luminal SR
Ca2+ which is slowly loaded via Ca2+ influx through Cav1.2
channels and partial downregulation of RyR2 is associated
with a compensatory uploading of the SR with Ca2+. In
our view, a preferable approach to reveal the specific roles
of RyR isoforms in arterial smooth muscle are experiments
on inducible, smooth muscle-specific knockout mice lacking
RyR subtypes. Generation of these mice is required for
further research and will give future advances in the field.
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